GC BIO

Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Mar 2026)

What this means for you

This application is over — abandoned 16 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
97298539
Mark type
Design + words
Filed
07 Mar 2022
Published for opposition
13 Dec 2022
Abandoned
16 Mar 2026
Attorney of record
Kwang Yup Chae

Goods and services

  • Class 005 — Pharmaceuticals: Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Medicated plasters; Vaccines; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Dietary and nutritional supplements
  • Class 035 — Advertising and business services: Wholesale distributorships and retail store services featuring pharmaceutical products; Export and import agencies in the field of pharmaceutical products; Wholesale store services featuring biological preparations for medical purposes; Retail store services featuring biological preparations for medical purposes; Retail store services featuring pharmaceutical preparations for the treatment of cells; Retail store services featuring medical instruments; Retail store services featuring medical apparatus; Retail store services featuring medical genetic analyzer; Retail store services featuring electromedical diagnostic instruments; Wholesale store services featuring pharmaceutical preparations for the treatment of cells; Wholesale store services featuring medical instruments; Wholesale store services featuring medical apparatus; Wholesale store services featuring medical genetic analyzer; Wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrial, institutional, commercial and janitorial equipment and supplies; Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; Operation of a business for others, namely, wholesale distributorships and retail stores featuring pharmaceutical products; Procurement, namely, purchasing pharmaceutical products for other businesses
  • Class 042 — Scientific and technological services: Research and development of vaccines and medicines; Research and development, laboratory and scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Conducting clinical studies of medicines for medical research purposes; Clinical research in the nature of performing biopsies for medical research; Product research and development of medical products; Conducting technical project studies, namely, engineering services in the nature of technical project planning and design engineering of medical products; Testing, inspection or research of pharmaceuticals; Scientific research relating to biology; Scientific research in the field of genetic engineering; Research and development of technology for biotechnology; Scientific research in the fields of biomedicine; Laboratory research in the field of biology; Product development of cell therapy products; Drug discovery services; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of gene analysis; Medical studies, namely, medical laboratory services; Research and development of technology for medicinal chemical manufacturing; Medical research services relating to clinical data

Owner

Prior registrations

Prosecution history

  • 16 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 16 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
  • 16 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 16 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
  • 28 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 28 Nov 2025 — SOU EXTENSION 5 GRANTED
  • 02 Jul 2025 — SOU EXTENSION 5 FILED
  • 02 Jul 2025 — SOU TEAS EXTENSION RECEIVED
  • 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 10 Jan 2025 — SOU EXTENSION 4 GRANTED
  • 10 Jan 2025 — SOU EXTENSION 4 FILED
  • 10 Jan 2025 — SOU TEAS EXTENSION RECEIVED
  • 25 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 25 Jun 2024 — SOU EXTENSION 3 GRANTED
  • 25 Jun 2024 — SOU EXTENSION 3 FILED

View this trademark record on Marksy